miR-221/222 cluster expression improves clinical stratification of non-muscle invasive bladder cancer (TaT1) patients' risk for short-term relapse and progression-Reference-Cited by-同舟云学术

miR-221/222 cluster expression improves clinical stratification of non-muscle invasive bladder cancer (TaT1) patients' risk for short-term relapse and progression

Published:2017-12-15 Issue:3 Volume:57 Page:150-161
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Tsikrika Foteini D.¹,Avgeris Margaritis¹,Levis Panagiotis K.²,Tokas Theodoros²,Stravodimos Konstantinos²,Scorilas Andreas¹^ORCID

Affiliation:

1. Department of Biochemistry and Molecular Biology, Faculty of Biology; National and Kapodistrian University of Athens, Panepistimiopolis; Athens 157 01 Greece

2. First Department of Urology; “Laiko” General Hospital, Medical School, National and Kapodistrian University of Athens, Agiou Thoma 17; Athens 115 27 Greece

Publisher

Wiley

Subject

Cancer Research,Genetics

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/gcc.22516/fullpdf

Reference54 articles.

1. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends;Antoni;Eur Urol.,2017

2. Global cancer statistics, 2012;Torre;CA Cancer J Clin.,2015

3. The economics of bladder cancer: costs and considerations of caring for this disease;Svatek;Eur Urol.,2014

4. Medscape. Urothelial carcinoma of the bladder: definition, treatment and future efforts;Prasad;Nat Rev Urol.,2011

5. Cancer treatment and survivorship statistics, 2016;Miller;CA Cancer J Clin.,2016

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Testing the accuracy of a four serum microRNA panel for the detection of primary bladder cancer: a discovery and validation study;Biomarkers;2024-05-30

2. The Role of miRNAs to Detect Progression, Stratify, and Predict Relevant Clinical Outcomes in Bladder Cancer;International Journal of Molecular Sciences;2024-02-11

3. Activating transcription factor 3 is a new biomarker correlation with renal clear cell carcinoma progression;International Journal of Immunopathology and Pharmacology;2024-01

4. Down-regulated ATF3 Promotes Renal Clear Cell Carcinoma Progression Through PAXIP1-AS2 and OIP5-AS1/ hsa-miR-221-3p/ATF3 Axis Regulation of Endoplasmic Reticulum Stress;2023-05-02

5. Noncoding RNAs as a potential biomarker for the prognosis of bladder cancer: a systematic review and meta-analysis;Expert Review of Molecular Diagnostics;2023-04-03